Optimer Pharmaceuticals (OPTR) Tops Q4 EPS Views; Revs Heavy
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q4 EPS of $0.28, $0.17 better than the analyst estimate of $0.11. Revenue for the quarter came in at $64.6 million versus the consensus estimate of $43.19 million.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
